A Trial to Compare the Efficacy, Safety, Pharmacokinetics and Immunogenicity of HD204 to Avastin® in Advanced Non-squamous Non-small Cell Lung Cancer Patients
Clinical trial NCT03390686 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03390686
- Sponsor
- Prestige Biopharma Limited
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-15
- Primary completion
- 2024-07-01
- Enrollment
- 650
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.